Literature DB >> 10706733

High susceptibility for cystic fibrosis human airway gland cells to produce IL-8 through the I kappa B kinase alpha pathway in response to extracellular NaCl content.

O Tabary1, S Escotte, J P Couetil, D Hubert, D Dusser, E Puchelle, J Jacquot.   

Abstract

Increasing evidence suggests that in airways from cystic fibrosis (CF) patients, inflammation may precede bacterial infection and be related to an endogenous dysregulation of proinflammatory cytokines in airway epithelial cells. Several investigators have reported that, in CF airway fluids, elevated NaCl concentrations may also contribute to the diseased state by inhibiting the bactericidal properties of airway fluid. Because many proinflammatory cytokines are transcriptionally regulated by the NF-kappa B, we investigated whether an elevated extracellular NaCl content in airway fluids significantly impaired the regulation of the NF-kappa B/I kappa B alpha complex and the chemokine IL-8 production in primary non-CF and CF human bronchial gland epithelial cells. Exposure of non-CF gland cells to hypotonic (85 mM) NaCl solution, compared with isotonic (115 mM) NaCl and hypertonic (170 mM) NaCl solutions, resulted in a significant decrease in IL-8 production that was paralleled by a strong inhibition of activated NF-kappa B associated with an increased cytosolic expression of I kappa B alpha and a decrease in the I kappa B kinase alpha protein level. In CF gland cells, we demonstrated that, compared with the high IL-8 in an hypertonic solution, the release of IL-8 was significantly reduced 2-fold in an isotonic solution and 5-fold in a hypotonic solution. Strikingly, exposure of CF bronchial gland cells to either hypotonic or isotonic milieu did not result in a marked inhibition of the activated NF-kappa B/I kappa B alpha system. This is the first demonstration that primary human CF bronchial gland cells exhibit abnormally high IL-8 production through constitutively activated NF-kappa B and high I kappa B kinase alpha level, whatever the hypo-, iso-, and hypertonic NaCl milieu.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706733     DOI: 10.4049/jimmunol.164.6.3377

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Lymphocytes in cystic fibrosis lung disease: a tale of two immunities.

Authors:  R B Moss
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

2.  Respiratory syncytial virus pathophysiology and affect of palivizumab in special populations: cystic fibrosis and immunosuppression.

Authors:  Michael E Speer
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

Review 3.  Role of endoplasmic reticulum stress in cystic fibrosis-related airway inflammatory responses.

Authors:  Carla M P Ribeiro; Richard C Boucher
Journal:  Proc Am Thorac Soc       Date:  2010-11

4.  Regulation of chemokine expression by NaCl occurs independently of cystic fibrosis transmembrane conductance regulator in macrophages.

Authors:  Amanda G Kostyk; Karen M Dahl; Murry W Wynes; Laurie A Whittaker; Daniel J Weiss; Roberto Loi; David W H Riches
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

5.  Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis.

Authors:  V Raia; L Maiuri; C Ciacci; I Ricciardelli; L Vacca; S Auricchio; M Cimmino; M Cavaliere; M Nardone; A Cesaro; J Malcolm; S Quaratino; M Londei
Journal:  Thorax       Date:  2005-06-30       Impact factor: 9.139

Review 6.  Monitoring inflammation in CF. Cytokines.

Authors:  Scott D Sagel; Frank J Accurso
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

7.  Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA.

Authors:  Yaqin Xu; Anja Krause; Hiroko Hamai; Ben-Gary Harvey; Tilla S Worgall; Stefan Worgall
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

8.  Dysregulation of IL-2 and IL-8 production in circulating T lymphocytes from young cystic fibrosis patients.

Authors:  C Hubeau; R Le Naour; M Abély; J Hinnrasky; M Guenounou; D Gaillard; E Puchelle
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

9.  Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease.

Authors:  Simon Y Graeber; Zhe Zhou-Suckow; Jolanthe Schatterny; Stephanie Hirtz; Richard C Boucher; Marcus A Mall
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

10.  Newborn Cystic Fibrosis Pigs Have a Blunted Early Response to an Inflammatory Stimulus.

Authors:  Jennifer A Bartlett; Shyam Ramachandran; Christine L Wohlford-Lenane; Carrie K Barker; Alejandro A Pezzulo; Joseph Zabner; Michael J Welsh; David K Meyerholz; David A Stoltz; Paul B McCray
Journal:  Am J Respir Crit Care Med       Date:  2016-10-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.